PYC Therapeutics is a development-stage biotechnology company pioneering a new generation of RNA therapeutics that utilize Cell Penetrating Peptides (CPPs), a revolutionary delivery technology designed to overcome the major challenges of current gene-based therapies.

Biotechnology

PYC Therapeutics

Sahm Nasseri

Rohan Hockings

Paula Cunningham

The board of directors at PYC Therapeutics has a history of experience in the industries of medical and pharmaceuticals. The board is made up of the Senior Partner at Flagship Pioneering, the Chief Medical Officer at Merck, and other experienced professionals in the field. This experience gives the board a wealth of knowledge to draw from when making decisions for the company.

Board of Directors

About

Team members

Other teams at PYC Therapeutics

Leadership Team

CEO and Executive Team